Research and Engagement
The School sits within the University’s College of Biomedical and Life Sciences, the latter integrating the research activities of a number of Schools alongside Pharmacy & Pharmaceutical Sciences, namely: Biosciences, Dentistry, Health Care Studies and Nursing and Midwifery Studies (both now within a newly formed School of Health Care Sciences), Optometry & Vision Science, Psychology, and Medicine.
One of the school’s strengths is the applied and multidisciplinary nature of its inquiries, benefiting from worldwide scientific collaborations and strategic relationships with global businesses and public sector bodies. The school’s external research awards of some £3m per annum are secured through partnerships with a diverse range of funding bodies (see Research-User Engagement)
Research in the Cardiff School of Pharmacy and Pharmaceutical Sciences encompasses all facets of the study of pharmaceuticals. The School's four disciplines (below) represent operational units providing platform knowledge and technical resource support. Although staff are located within a specific discipline much of the research is cross-disciplinary, also involving collaborations with many other groups across the University and elsewhere. Research in the laboratory-based sciences covers a spectrum of disease areas including cancer, infection, cardiovascular, musculo-skeletal, respiratory and neurological disorders. This work seeks to identify fundamental mechanisms of disease and new pharmacological targets, the design of novel drug candidates and of innovative drug delivery systems. Complementing the activities of the laboratory sciences are academic staff engaged in understanding the social and psychological aspects of the medicines-patient interface, measuring patients’ quality of life and associated issues around medicines resource allocation.
Some Research performance indicators in the period (2008-2013) include:
- Research income directly to the School of ca.£17.2M
- Significant collaboration with external partners on projects of direct translational significance, for example 55% of the School’s research income is from awards made by commerce, central government and devolved government bodies such as NISCHR/NIHR, with the remaining from RCUK, medical charities and EC.
- License income £1.45M and fifteen patents granted
- Graduation of 95 PhD doctoral researchers
- Publication of 670 peer reviewed original articles yielding 8200 citations
Designing and synthesising novel active compounds as drug candidates.